Cofilin as a Promising Therapeutic Target for Ischemic and Hemorrhagic Stroke

Translational Stroke Research

Volumn 7, Issue 1, 2016, Pages 33-41

  Alhadidi, Qasim ^a   Bin Sayeed, Muhammad Shahdaat ^b   Shah, Zahoor A ^a,b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

Author keywords

Cofilin; Intracranial hemorrhage; Ischemic stroke; Neurovascular unit

Indexed keywords

COFILIN; ACTIN DEPOLYMERIZING FACTOR;

ACTIN FILAMENT; APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CELL DEATH; CELL DIFFERENTIATION; CELL INTERACTION; CELLULAR DISTRIBUTION; DEPHOSPHORYLATION; DISEASE COURSE; EXCITOTOXICITY; INFLAMMATION; MYELINATION; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; REMYELINIZATION; REVIEW; ANIMAL; DRUG EFFECTS; HUMAN; INTRACRANIAL HEMORRHAGES; METABOLISM; STROKE;

ACTIN DEPOLYMERIZING FACTORS; ANIMALS; BRAIN ISCHEMIA; HUMANS; INTRACRANIAL HEMORRHAGES; STROKE;

EID: 84955370406     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-015-0438-2     Document Type: Review

References (134)

1. Mozaffarian D et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.
2. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67(2):181–98.
3. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391–7.
4. Kleinig TJ, Vink R. Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Curr Opin Neurol. 2009;22(3):294–301.
5. Kitagawa K. CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J. 2007;274(13):3210–7.
6. Terasaki Y et al. Mechanisms of neurovascular dysfunction in acute ischemic brain. Curr Med Chem. 2014;21(18):2035–42.
7. Lok J et al. Intracranial hemorrhage: mechanisms of secondary brain injury. Acta Neurochir Suppl. 2011;111:63–9.
8. Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke. 2011;42(6):1781–6.
9. Lyden P et al. Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results. Stroke. 2002;33(1):122–8.
10. Shuaib A et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med. 2007;357(6):562–71.
11. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4(5):399–415.
12. Gladstone DJ et al. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33(8):2123–36.
13. Taylor RA, Sansing LH. Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol. 2013;2013:746068.
14. Rosell A, Lo EH. Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol. 2008;8(1):82–9.
15. Hayakawa K, Qiu J, Lo EH. Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann N Y Acad Sci. 2010;1207:50–7.
16. Van Troys M et al. Ins and outs of ADF/cofilin activity and regulation. Eur J Cell Biol. 2008;87(8–9):649–67.
17. Bellenchi GC et al. N-cofilin is associated with neuronal migration disorders and cell cycle control in the cerebral cortex. Genes Dev. 2007;21(18):2347–57.
18. Andrianantoandro E, Pollard TD. Mechanism of actin filament turnover by severing and nucleation at different concentrations of ADF/cofilin. Mol Cell. 2006;24(1):13–23.
19. Chan C, Beltzner CC, Pollard TD. Cofilin dissociates Arp2/3 complex and branches from actin filaments. Curr Biol. 2009;19(7):537–45.
20. Niwa R et al. Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin. Cell. 2002;108(2):233–46.
21. Ambach A et al. The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes. Eur J Immunol. 2000;30(12):3422–31.
22. Gohla A, Birkenfeld J, Bokoch GM. Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics. Nat Cell Biol. 2005;7(1):21–9.
23. Kim JS, Huang TY, Bokoch GM. Reactive oxygen species regulate a slingshot-cofilin activation pathway. Mol Biol Cell. 2009;20(11):2650–60.
24. Wang Y, Shibasaki F, Mizuno K. Calcium signal-induced cofilin dephosphorylation is mediated by Slingshot via calcineurin. J Biol Chem. 2005;280(13):12683–9.
25. Huang TY et al. Chronophin mediates an ATP-sensing mechanism for cofilin dephosphorylation and neuronal cofilin-actin rod formation. Dev Cell. 2008;15(5):691–703.
26. Park S, Jung Y. Combined actions of Na/K-ATPase, NCX1 and glutamate dependent NMDA receptors in ischemic rat brain penumbra. Anat Cell Biol. 2010;43(3):201–10.
27. Bamburg JR et al. ADF/cofilin-actin rods in neurodegenerative diseases. Curr Alzheimer Res. 2010;7(3):241–50.
28. Bamburg JR. Proteins of the ADF/cofilin family: essential regulators of actin dynamics. Annu Rev Cell Dev Biol. 1999;15:185–230.
29. Huang TY, DerMardirossian C, Bokoch GM. Cofilin phosphatases and regulation of actin dynamics. Curr Opin Cell Biol. 2006;18(1):26–31.
30. Bailly M, Jones GE. Polarised migration: cofilin holds the front. Curr Biol. 2003;13(4):R128–30.
31. Nusco GA et al. Modulation of calcium signalling by the actin-binding protein cofilin. Biochem Biophys Res Commun. 2006;348(1):109–14.
32. Ohashi K. Roles of cofilin in development and its mechanisms of regulation. Dev Growth Differ. 2015;57(4):275–90.
33. Schonhofen P et al. Cofilin/actin rod formation by dysregulation of cofilin-1 activity as a central initial step in neurodegeneration. Mini Rev Med Chem. 2014;14(5):393–400.
34. Maki T et al. Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases. CNS Neurol Disord Drug Targets. 2013;12(3):302–15.
35. Carmichael ST. Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann Neurol. 2006;59(5):735–42.
36. Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 2012;11(4):369–80.
37. Kriz J, Lalancette-Hebert M. Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol. 2009;117(5):497–509.
38. Murphy TH, Corbett D. Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci. 2009;10(12):861–72.
39. Wolf M et al. ADF/cofilin controls synaptic actin dynamics and regulates synaptic vesicle mobilization and exocytosis. Cereb Cortex. 2015;25(9):2863–75.
40. Gu J et al. ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticity. Nat Neurosci. 2010;13(10):1208–15.
41. Yuen EY et al. Regulation of AMPA receptor channels and synaptic plasticity by cofilin phosphatase Slingshot in cortical neurons. J Physiol. 2010;588(Pt 13):2361–71.
42. Rust MB et al. Learning, AMPA receptor mobility and synaptic plasticity depend on n-cofilin-mediated actin dynamics. EMBO J. 2010;29(11):1889–902.
43. Arvidsson A et al. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med. 2002;8(9):963–70.
44. Zhang RL et al. Patterns and dynamics of subventricular zone neuroblast migration in the ischemic striatum of the adult mouse. J Cereb Blood Flow Metab. 2009;29(7):1240–50.
45. Nawaz S et al. Actin filament turnover drives leading edge growth during myelin sheath formation in the central nervous system. Dev Cell. 2015;34(2):139–51.
46. Pedraza, C.E., et al., Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase. ASN Neuro, 2014. 6(4).
47. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796–808.
48. Napoli I, Neumann H. Protective effects of microglia in multiple sclerosis. Exp Neurol. 2010;225(1):24–8.
49. Gitik M et al. Phagocytic receptors activate and immune inhibitory receptor SIRPalpha inhibits phagocytosis through paxillin and cofilin. Front Cell Neurosci. 2014;8:104.
50. Cao W et al. Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neurosci Lett. 1988;88(2):233–8.
51. Floyd RA et al. Translational research involving oxidative stress and diseases of aging. Free Radic Biol Med. 2011;51(5):931–41.
52. Gouriou Y et al. Mitochondrial calcium handling during ischemia-induced cell death in neurons. Biochimie. 2011;93(12):2060–7.
53. Zhang Y et al. Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J Neurosci. 2004;24(47):10616–27.
54. Klamt F et al. Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat Cell Biol. 2009;11(10):1241–6.
55. Wabnitz GH et al. Mitochondrial translocation of oxidized cofilin induces caspase-independent necrotic-like programmed cell death of T cells. Cell Death Dis. 2010;1:e58.
56. Madineni, A., Q. Alhadidi, and Z.A. Shah, Cofilin inhibition restores neuronal cell death in oxygen-glucose deprivation model of ischemia. Mol Neurobiol, 2015. doi:10.1007/s12035-014-9056-3.
57. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008;14(5):497–500.
58. Hayakawa K et al. Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells. J Neurosci. 2011;31(29):10666–70.
59. Cavaliere F et al. Oligodendrocyte differentiation from adult multipotent stem cells is modulated by glutamate. Cell Death Dis. 2012;3:e268.
60. Fleissner F, Thum T. Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxid Redox Signal. 2011;15(4):933–48.
61. Miller AA, Drummond GR, Sobey CG. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther. 2006;111(3):928–48.
62. Pacher P, Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am J Pathol. 2008;173(1):2–13.
63. Lee MY et al. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol. 2009;29(4):480–7.
64. Juurlink BH, Thorburne SK, Hertz L. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia. 1998;22(4):371–8.
65. Mronga T et al. Mitochondrial pathway is involved in hydrogen-peroxide-induced apoptotic cell death of oligodendrocytes. Glia. 2004;46(4):446–55.
66. Lindenau J et al. Cellular distribution of superoxide dismutases in the rat CNS. Glia. 2000;29(1):25–34.
67. Dringen R, Gutterer JM, Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem. 2000;267(16):4912–6.
68. Chen Y et al. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J Neurochem. 2001;77(6):1601–10.
69. Wang Y, Qin ZH. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis. 2010;15(11):1382–402.
70. Mabuchi T et al. Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci. 2001;21(23):9204–13.
71. Choi DW, Maulucci-Gedde M, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurosci. 1987;7(2):357–68.
72. Kostandy BB. The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci. 2012;33(2):223–37.
73. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci. 2001;69(4):369–81.
74. Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 2000;403(6767):316–21.
75. Posadas I et al. Cofilin activation mediates Bax translocation to mitochondria during excitotoxic neuronal death. J Neurochem. 2012;120(4):515–27.
76. Chen B et al. Both NMDA and non-NMDA receptors mediate glutamate stimulation induced cofilin rod formation in cultured hippocampal neurons. Brain Res. 2012;1486:1–13.
77. Sutherland BA et al. Cerebral blood flow alteration in neuroprotection following cerebral ischaemia. J Physiol. 2011;589(Pt 17):4105–14.
78. Duffney LJ et al. Shank3 deficiency induces NMDA receptor hypofunction via an actin-dependent mechanism. J Neurosci. 2013;33(40):15767–78.
79. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia. 2000;32(1):1–14.
80. Martinez-Hernandez A, Bell KP, Norenberg MD. Glutamine synthetase: glial localization in brain. Science. 1977;195(4284):1356–8.
81. Chaudhry FA et al. Glutamine uptake by neurons: interaction of protons with system a transporters. J Neurosci. 2002;22(1):62–72.
82. Kvamme E, Roberg B, Torgner IA. Phosphate-activated glutaminase and mitochondrial glutamine transport in the brain. Neurochem Res. 2000;25(9–10):1407–19.
83. McKenna MC. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J Neurosci Res. 2007;85(15):3347–58.
84. Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65(1):1–105.
85. Adolph O et al. Rapid increase of glial glutamate uptake via blockade of the protein kinase A pathway. Glia. 2007;55(16):1699–707.
86. Sheean RK et al. Links between L-glutamate transporters, Na+/K + −ATPase and cytoskeleton in astrocytes: evidence following inhibition with rottlerin. Neuroscience. 2013;254:335–46.
87. Yan X et al. Interleukin-1 beta enhances endocytosis of glial glutamate transporters in the spinal dorsal horn through activating protein kinase C. Glia. 2014;62(7):1093–109.
88. Funfschilling U et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485(7399):517–21.
89. Wilkins A et al. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci. 2003;23(12):4967–74.
90. Dewar D, Underhill SM, Goldberg MP. Oligodendrocytes and ischemic brain injury. J Cereb Blood Flow Metab. 2003;23(3):263–74.
91. Karadottir R et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature. 2005;438(7071):1162–6.
92. Yoshioka A et al. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem. 1995;64(6):2442–8.
93. Simonishvili S et al. Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia. ASN Neuro. 2013;5(5):e00131.
94. Mathur BN, Deutch AY. Rat meningeal and brain microvasculature pericytes co-express the vesicular glutamate transporters 2 and 3. Neurosci Lett. 2008;435(2):90–4.
95. Sharp CD et al. Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor. Am J Physiol Heart Circ Physiol. 2003;285(6):H2592–8.
96. Basuroy S, Leffler CW, Parfenova H. CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis. Am J Physiol Cell Physiol. 2013;304(11):C1105–15.
97. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57–69.
98. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50(4):427–34.
99. Takano T et al. Astrocytes and ischemic injury. Stroke. 2009;40(3 Suppl):S8–12.
100. Barreto GE et al. Astrocyte proliferation following stroke in the mouse depends on distance from the infarct. PLoS One. 2011;6(11):e27881.
101. Wagner KR. Modeling intracerebral hemorrhage: glutamate, nuclear factor-kappa B signaling and cytokines. Stroke. 2007;38(2 Suppl):753–8.
102. Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol. 2010;92(4):463–77.
103. Luo XG, Chen SD. The changing phenotype of microglia from homeostasis to disease. Transl Neurodegener. 2012;1(1):9.
104. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008;8(4):279–89.
105. Zhou Y et al. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014;115:25–44.
106. Lee Y et al. Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke. Biomed Res Int. 2014;2014:297241.
107. Jin R et al. Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res. 2013;6(5):834–51.
108. Jonsson F et al. Immunological responses and actin dynamics in macrophages are controlled by N-cofilin but are independent from ADF. PLoS One. 2012;7(4):e36034.
109. Li J et al. Caspase-11 regulates cell migration by promoting Aip1-Cofilin-mediated actin depolymerization. Nat Cell Biol. 2007;9(3):276–86.
110. Rasmussen I et al. Effects of F/G-actin ratio and actin turn-over rate on NADPH oxidase activity in microglia. BMC Immunol. 2010;11:44.
111. Hadas S et al. Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin. J Neuroinflammation. 2012;9:166.
112. Fu R et al. Phagocytosis of microglia in the central nervous system diseases. Mol Neurobiol. 2014;49(3):1422–34.
113. Walsh KP et al. Amyloid-beta and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons. PLoS One. 2014;9(4):e95995.
114. Engelhardt S, Patkar S, Ogunshola OO. Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia. Br J Pharmacol. 2014;171(5):1210–30.
115. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol. 2008;130(1):55–70.
116. Structure and function of the blood-brain barrier. 2010. 37(1): p. 13–25.
117. Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42(11):3323–8.
118. Keep RF et al. Vascular disruption and blood-brain barrier dysfunction in intracerebral hemorrhage. Fluids Barriers CNS. 2014;11:18.
119. Koto T et al. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol. 2007;170(4):1389–97.
120. Bauer AT et al. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab. 2010;30(4):837–48.
121. Willis CL, Meske DS, Davis TP. Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab. 2010;30(11):1847–59.
122. Kondo N et al. Thrombin induces rapid disassembly of claudin-5 from the tight junction of endothelial cells. Exp Cell Res. 2009;315(17):2879–87.
123. Moller T, Weinstein JR, Hanisch UK. Activation of microglial cells by thrombin: past, present, and future. Semin Thromb Hemost. 2006;32 Suppl 1:69–76.
124. Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27(5):894–908.
125. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res. 2009;77(1):53–63.
126. Engelhardt S et al. Differential responses of blood-brain barrier associated cells to hypoxia and ischemia: a comparative study. Fluids Barriers CNS. 2015;12:4.
127. Liu LB et al. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton. J Neurosci Res. 2008;86(5):1153–68.
128. Suurna MV et al. Cofilin mediates ATP depletion-induced endothelial cell actin alterations. Am J Physiol Renal Physiol. 2006;290(6):F1398–407.
129. Toshima J et al. Cofilin phosphorylation by protein kinase testicular protein kinase 1 and its role in integrin-mediated actin reorganization and focal adhesion formation. Mol Biol Cell. 2001;12(4):1131–45.
130. Kobayashi M et al. MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J. 2006;25(4):713–26.
131. Nagumo Y et al. Cofilin mediates tight-junction opening by redistributing actin and tight-junction proteins. Biochem Biophys Res Commun. 2008;377(3):921–5.
132. Shiobara T et al. The reversible increase in tight junction permeability induced by capsaicin is mediated via cofilin-actin cytoskeletal dynamics and decreased level of occludin. PLoS One. 2013;8(11):e79954.
133. Leonard A et al. Thrombin selectively engages LIM kinase 1 and slingshot-1L phosphatase to regulate NF-kappaB activation and endothelial cell inflammation. Am J Physiol Lung Cell Mol Physiol. 2013;305(9):L651–64.
134. Tominaga N et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun. 2015;6:6716.